| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-8049(01)00273-8 |
| P698 | PubMed publication ID | 11677110 |
| P2093 | author name string | Lock RB | |
| Catchpoole DR | |||
| P2860 | cites work | Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II | Q22010404 |
| Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development | Q24317252 | ||
| Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 | Q24324482 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Caspases: killer proteases | Q29616315 | ||
| Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 | Q29618617 | ||
| NCBI's LocusLink and RefSeq | Q30825874 | ||
| International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma | Q34169642 | ||
| Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. | Q34197920 | ||
| A proposed staging for children with neuroblastoma.Children's cancer study group A | Q34701554 | ||
| A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. | Q36380492 | ||
| A physical map of 30,000 human genes | Q38476708 | ||
| Why does stage 4s neuroblastoma regress spontaneously? | Q40625916 | ||
| A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis | Q40980300 | ||
| Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. | Q53425055 | ||
| Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN | Q73766132 | ||
| Interleukin-1 beta converting enzyme (ICE) is preferentially expressed in neuroblastomas with favourable prognosis | Q74360636 | ||
| Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
| P433 | issue | 17 | |
| P304 | page(s) | 2217-2221 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma. | |
| P478 | volume | 37 |
| Q34172531 | Ataxin-2 promotes apoptosis of human neuroblastoma cells |
| Q33911332 | Caspase inhibition blocks cell death and enhances mitophagy but fails to promote T-cell lymphoma |
| Q34447887 | Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas |
| Q35903564 | Mitochondrial dysfunction in cancer |
| Q38874193 | Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death |
| Q39034124 | Network understanding of herb medicine via rapid identification of ingredient-target interactions |
| Q24681706 | Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis |
| Q37342739 | The enigmatic roles of caspases in tumor development |
Search more.